How these ASX IPOs fared 1 week later

This is how the latest shares listing on the ASX performed.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The first week of a company being on the ASX boards can be very telling. The market doesn't get any new information until the next quarterly or half-year result, so we can get a sense of the market sentiment from how the share does in its first week.

Of course, how the market treats a share doesn't ultimately mean anything. But, it can be interesting nonetheless.

If you want to learn more about a share below, I suggest you dig into the prospectus.

Here are how the latest ASX Ltd (ASX: ASX) shares fared:

AXS Group Limited (ASX: AXS)

AXS Group's principal activity is being an integrated software solution provider to the finance, insurance and funds sector.

The software is used to originate and service any asset class until the end of its use. Its clients have entered over $100 billion in assets and in transactions onto the software platform. It aims to save time, reduce labour & workflows and lower costs for organisations.

It was looking to raise $7 million at $0.25 per share and start trading on 28 November 2018. It didn't make it onto the ASX boards and as of today there isn't a new expected listing date.

EMvision Medical Devices Limited (ASX: EMV)

EMvision Medical Devices' principal activity is the development and commercialisation of medical imaging technology.

The company's technology is used to create images of the brain and other organs. EMvision says the technology is non-invasive, safe and cost-effective. Its initial focus is neurological conditions, specifically stroke care. The CEO, Dr Ron Weinberger, used to be the CEO of Nanosonics Ltd (ASX: NAN).

EMvision was looking to raise $6 million at $0.25 per share and start trading on 30 November 2018. It also didn't make it onto the ASX and there isn't another expected listing date.

Qualitas Real Estate Income Fund (ASX: QRI)

Its principal activity is as a listed investment trust (LIT) investing in secured real estate loans in Australia and New Zealand.

The LIT will try to provide monthly income and capital preservation by investing in a portfolio of investments that offers exposure to real estate loans secured by first and second mortgages, mostly located in Australia. It's targeting an 8% return per annum after fees and expenses.

It was looking to raise $500 million at $1.60 per share and then list on 27 November 2018. It's now trading at $1.65, meaning it has gone up by 3% since listing.

Redcape Hotel Group (ASX: RDC)

Redcape's principal activity is owning and operating pubs & hotel in Australia.

It owns 29 venues, along with 21 bottle shops, three accommodation venues and The Australian Brewery.

Redcape was looking to raise $60 million at $1.13 per share and list on 30 November 2018. It's now trading at $1.05, meaning it has dropped 7% since listing. It has launched a buyback to support the share price.

Foolish takeaway

With rising interest rates, owning debt could actually be a useful investment, but I'm wary of real estate loans at this stage in the cycle.

Redcape would be the only one I'd consider investing in, but it's not the type of business I'd want to invest in. I think there are better options out there for your portfolio.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of ASX Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Capital Raising

A man sits in a chair hunched over a laptop and covered head to toe in frozen icicles to represent Envirosuite's trading halt
Capital Raising

DroneShield shares freeze on $75 million for AI and inventory

This defence tech stock is rattling the can for a chunk of cash.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Technology Shares

What's happening with the NextDC share price on Thursday?

NextDC is raising $1.32 billion to accelerate its data centre developments amid the rapid growth of AI.

Read more »

A man sits in a chair hunched over a laptop and covered head to toe in frozen icicles to represent Envirosuite's trading halt
Capital Raising

Up 102% in 2024, here's why this ASX All Ords stock is now frozen

Seize the day. This company is ready to cash in on its renewed image.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Materials Shares

Why is this ASX 300 battery materials stock crashing 20% today?

Its shares are now down by 67% since this time last year.

Read more »

A man with a heavy facial hair growth and a comical look on his face holds his hands in a 'time out' gesture.
Energy Shares

Up 90% in a year, why is this ASX 300 uranium stock suddenly halted?

Here's why this high-flying stock is out of action today.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Mergers & Acquisitions

Why are Metcash shares tumbling today?

This wholesaler has just received a $300 million cash injection.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Materials Shares

Why is the Arafura share price sinking 17% today?

It has been a tough session for this rare earths stock. But why?

Read more »

Two happy pharmacists standing together in a pharmacy.
Capital Raising

Own Sigma shares? Everything you need to know about the 'transformational' $8.8b merger with Chemist Warehouse

Here's what you need to know about this mega merger.

Read more »